Furthermore, CD40L/CD40-mediated interaction between CLL and T-cells facilitates increased expression of anti-apoptotic proteins, such as BCL-XL and MCL-1 and significantly reduced sensitivity to venetoclax [49]. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.